4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-099071
Director sold 248,675 shares at an average $45.48 ($11,310,183)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kersten Dirk Director | 2024-08-16 | Sale 10b5-1 | −34,485 | $44.52 | $1,535,272 | 1,337,663 | I |
| Kersten Dirk Director | 2024-08-16 | Sale 10b5-1 | −85,086 | $45.35 | $3,858,650 | 1,252,577 | I |
| Kersten Dirk Director | 2024-08-16 | Sale 10b5-1 | −3,072 | $46.19 | $141,896 | 1,249,505 | I |
| Kersten Dirk Director | 2024-08-19 | Sale 10b5-1 | −30,448 | $45.10 | $1,373,205 | 1,219,057 | I |
| Kersten Dirk Director | 2024-08-19 | Sale 10b5-1 | −89,824 | $46.01 | $4,132,802 | 1,129,233 | I |
| Kersten Dirk Director | 2024-08-19 | Sale 10b5-1 | −5,760 | $46.59 | $268,358 | 1,123,473 | I |
| Open-market sales · 248,675 sh · avg $45.48 · $11,310,183 | |||||||
Loading xslF345X05/ownership.xml…